NCT05379153 Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial Status RECRUITING Phase PHASE3
NCT05334069 Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection Status RECRUITING Phase N/A
NCT05008848 Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program Status RECRUITING Phase PHASE3
NCT04939090 Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04803201 Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma Status SUSPENDED Phase PHASE2
NCT04242095 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects Status RECRUITING Phase N/A
NCT04114981 Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03994796 Genetic Testing in Guiding Treatment for Patients With Brain Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03927027 Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03857620 Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT03633331 Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT03609216 Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03550391 Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases Status RECRUITING Phase PHASE3
NCT03488693 Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer Status RECRUITING Phase PHASE3
NCT03150693 Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE3
NCT02523014 Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas Status RECRUITING Phase PHASE2
NCT01905046 Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01150045 Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Status COMPLETED Phase PHASE3
NCT00558519 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00376597 Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection Status COMPLETED Phase N/A